Table 2.
Commercialised assays, based on the detection of coproantigens, for the diagnosis of gastrointestinal tract infections caused by protozoa.
| Protozoa | Diagnosis method | Manufacturer |
|---|---|---|
| Entamoeba histolytica | ELISA | Cellabs |
| Remel | ||
| TechLab | ||
| Membrane EIA | TechLab | |
| ICT | CerTest biotec | |
| Giardia lamblia | ELISA | Cellabs |
| Remel | ||
| TechLab | ||
| ICT | CerTest biotec | |
| Remel | ||
| IFD | Cellabs | |
| Cryptosporidium | ELISA | Remel |
| TechLab | ||
| ICT | CerTest biotec | |
| Remel | ||
| IFD | Cellabs | |
| G. lamblia and Cryptosporidium | ELISA | Remel |
| Membrane EIA | TechLab | |
| ICT | Becton Dickinson | |
| CerTest biotec | ||
| Meridian Bioscience | ||
| Remel | ||
| IFD | Cellabs | |
| Medical Chemical Corporation | ||
| Meridian Bioscience | ||
| Cryptosporidium, G. lamblia and E. histolytica/dispar | ICT | CerTest biotec TechLab |